NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Captain - I was just about to raise that question also. It appears to be a Vaccine based treatment from the name given to the product. But, I would surmise to say it doesn't involve near the same complexity, number of steps, or logistics compared to DCVAX. It stands to reason it would cost less? How many Vaccine preparations are required? It's not personalized, but rather, "Tumor associated “survivin” is expressed in >95% of nGBM and targetable by SurVaxM immunotherapy."
So it's not personalized, like DCVax, which means it's more an off the shelf product like Kaytruda.
We also know that Merck is running a combo trial.
This kind of thing gives me more pose than C share bantering.

ILT